Genprex (GNPX) had the highest return between October 21, 2024 and October 29, 2024 by a US stock, returning 343.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Genprex (GNPX) | 10/21/2024 - 10/29/2024 | 343.64% |
Anghami Inc Warrants (ANGHW) | 10/21/2024 - 10/29/2024 | 257.27% |
Monopar Therapeutics (MNPR) | 10/21/2024 - 10/29/2024 | 197.98% |
Coeptis Therapeutics (COEPW) | 10/21/2024 - 10/29/2024 | 172.56% |
Healthcare Triangle (HCTI) | 10/21/2024 - 10/29/2024 | 164.25% |
Upexi (UPXI) | 10/21/2024 - 10/29/2024 | 138.83% |
Ensysce Biosciences (ENSC) | 10/21/2024 - 10/29/2024 | 126.28% |
Sol Strategies Inc Common Shares (STKE) | 10/21/2024 - 10/29/2024 | 119.3% |
Sangamo Therapeutics (SGMO) | 10/21/2024 - 10/29/2024 | 118.99% |
Nexalin Technology (NXLIW) | 10/21/2024 - 10/29/2024 | 114.81% |
Nexalin Technology (NXL) | 10/21/2024 - 10/29/2024 | 107.14% |
Biofrontera Inc Warrants (BFRIW) | 10/21/2024 - 10/29/2024 | 104.19% |
Streamex (STEX) | 10/21/2024 - 10/29/2024 | 100% |
Fitell Corporation Ordinary Shares (FTEL) | 10/21/2024 - 10/29/2024 | 97.47% |
SBC Medical (SBCWW) | 10/21/2024 - 10/29/2024 | 97.4% |
Trump Media & Technology (DJTWW) | 10/21/2024 - 10/29/2024 | 84.09% |
J-Long Group Limited Ordinary Shares (JL) | 10/21/2024 - 10/29/2024 | 81% |
Bolt Projects (BSLKW) | 10/21/2024 - 10/29/2024 | 80% |
Nova Minerals Limited Warrant (NVAWW) | 10/21/2024 - 10/29/2024 | 75.6% |
Mingteng International Corporation Inc Ordinary Shares (MTEN) | 10/21/2024 - 10/29/2024 | 73.33% |
Leap Therapeutics (LPTX) | 10/21/2024 - 10/29/2024 | 72.01% |
Trump Media & Technology (DJT) | 10/21/2024 - 10/29/2024 | 71.76% |
Monte Rosa Therapeutics (GLUE) | 10/21/2024 - 10/29/2024 | 70.05% |
Grab Holdings Limited Warrant (GRABW) | 10/21/2024 - 10/29/2024 | 69.73% |
BIO-Key International (BKYI) | 10/21/2024 - 10/29/2024 | 68.28% |
